Nitecapone
Chemical compound
- None
- 3-[(3,4-Dihydroxy-5-nitrophenyl)methylidene]pentane-2,4-dione
- 116313-94-1
- 5464105
- 4576539
- 98BS722498
- D03241
- ChEMBL167055
- DTXSID80151347
- Interactive image
- [O-][N+](=O)c1cc(\C=C(/C(=O)C)C(=O)C)cc(O)c1O
InChI
- InChI=1S/C12H11NO6/c1-6(14)9(7(2)15)3-8-4-10(13(18)19)12(17)11(16)5-8/h3-5,16-17H,1-2H3
- Key:UPMRZALMHVUCIN-UHFFFAOYSA-N
Nitecapone (INN; OR-462) is a drug which acts as a selective inhibitor of the enzyme catechol O-methyl transferase (COMT).[1][2] It was patented as an antiparkinson medication but was never marketed.[1]
See also
- Catechol-O-methyltransferase inhibitor
References
- ^ a b F.. Macdonald (1997). Dictionary of Pharmacological Agents. CRC Press. p. 1635. ISBN 978-0-412-46630-4. Retrieved 20 May 2012.
- ^ Nissinen E, Lindén IB, Schultz E, Kaakkola S, Männistö PT, Pohto P (August 1988). "Inhibition of catechol-O-methyltransferase activity by two novel disubstituted catechols in the rat". European Journal of Pharmacology. 153 (2–3): 263–9. doi:10.1016/0014-2999(88)90614-0. PMID 3181288.
- v
- t
- e
DA precursors | |
---|---|
DA receptor agonists |
|
MAO-B inhibitors | |
COMT inhibitors | |
AAAD inhibitors |
- #WHO-EM
- ‡Withdrawn from market
- Clinical trials:
- †Phase III
- §Never to phase III
![]() | This drug article relating to the nervous system is a stub. You can help Wikipedia by expanding it. |
- v
- t
- e